Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI

Molecular Imaging and Biology

Volumn 15, Issue 2, 2013, Pages 155-165

  Schmid, Andreas ^a   Schmitz, Jennifer ^a   Mannheim, Julia G ^a   Maier, Florian C ^a   Fuchs, Kerstin ^a   Wehrl, Hans F ^a   Pichler, Bernd J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Benchtop MRI; Multimodal imaging; PET MRI; Small animal PET

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EQUIPMENT DESIGN; FEASIBILITY STUDY; FEMALE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; IMAGING PHANTOM; IMAGING SYSTEM; IN VIVO STUDY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANIMALIA;

EID: 84878320589     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-012-0577-8     Document Type: Article

References (30)

1. Cherry SR (2004) In vivo molecular and genomic imaging: new challenges for imaging physics. Phys Med Biol 49:R13-R48
2. Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med Off Publ Soc Nucl Med 41:1369-1379
3. Judenhofer MS, Wehrl HF, Newport DF et al (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14:459-465
4. Delso G, Furst S, Jakoby B et al (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med Off Publ Soc Nucl Med 52:1914-1922
5. Pichler BJ, Wehrl HF, Judenhofer MS (2008) Latest advances in molecular imaging instrumentation. J Nucl Med Off Publ Soc Nucl Med 49(Suppl 2):5S-23S
6. Schlemmer HP, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028-1035
7. Buscher K, Judenhofer MS, Kuhlmann MT et al (2010) Isochronous assessment of cardiac metabolism and function in mice using hybrid PET/MRI. J Nucl Med Off Publ Soc Nucl Med 51:1277-1284
8. Zieker D, Konigsrainer I, Weinreich J et al (2010) Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging. Cell Physiol Biochem 26:147-154
9. Alberini JL, Edeline V, Giraudet AL et al (2011) Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer. J Surg Oncol 103:602-606
10. Sauter AW, Wehrl HF, Kolb A et al (2010) Combined PET/MRI: one step further in multimodality imaging. Trends Mol Med 16:508-515
11. Talbot JN, Fartoux L, Balogova S et al (2010) Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 51:1699-1706
12. Wissmeyer M, Heinzer S, Majno P et al (2011) Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging 38:1744-1745
13. Willekens I, Lahoutte T, Buls N et al (2009) Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC. Mol Imaging Biol 11:128-135
14. Constantinescu CC, Mukherjee J (2009) Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol 54:2885-2899
15. Mannheim JG, Judenhofer MS, Schmid A et al (2012) Quantification accuracy and partial volume effect in dependence of the attenuation correction of a state-of-the-art small animal PET scanner. Phys Med Biol 57:3981-3993
16. Kouskoff V, Korganow AS, Duchatelle V et al (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811-822
17. Matsumoto I, Staub A, Benoist C et al (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732-1735
18. Kneilling M, Hultner L, Pichler BJ et al (2007) Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum 56:1806-1816
19. Bergers G, Javaherian K, Lo KM et al (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284:808-812
20. Hanahan D (1985) Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122
21. Muller-Hermelink N, Braumuller H, Pichler B et al (2008) TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13:507-518
22. Schmid A, Braumuller H, Wehrl HF, et al (2011) Non-invasive monitoring of pancreatic tumor progression in the RIP1-Tag2 mouse by magnetic resonance imaging. Mol Imaging Biol. doi: 10.1007/s11307-012-0548-0
23. Kukuk D, Reischl G, Raguin O et al (2011) Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models. J Nucl Med Off Publ Soc Nucl Med 52:1654-1663
24. Bovens SM, te Boekhorst BC, den Ouden K et al (2011) Evaluation of infarcted murine heart function: comparison of prospectively triggered with self-gated MRI. NMR Biomed 24:307-315
25. Wehrl HF, Judenhofer MS, Wiehr S et al (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):S56-S68
26. Disler DG, McCauley TR, Ratner LM et al (1997) In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. AJR Am J Roentgenol 169:1439-1447
27. Rinck PA, Muller RN (1999) Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol 9:998-1004
28. Besheer A, Caysa H, Metz H et al (2011) Benchtop-MRI for in vivo imaging using a macromolecular contrast agent based on hydroxyethyl starch (HES). Int J Pharm 417:196-203
29. Caysa H, Metz H, Mader K et al (2011) Application of benchtop-magnetic resonance imaging in a nude mouse tumor model. J Exp Clin Cancer Res 30:69
30. Kempe S, Metz H, Pereira PG et al (2010) Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy. Eur J Pharm Biopharm 74:102-108